Skip to content

State coverage

Missouri

State Medicaid · 5 documents cited

Medicaid, for obesity: Covers with conditions. The conditions and the appeal deadline are in the summary below.

At a glance

Covers with conditions
Medicaid, for obesity
Covered since January 2025, with Zepbound preferred. Wegovy is not covered for weight loss itself.
Appeal deadline
90 days from the notice to appeal a refusal; 10 days if the state is cutting something you already have source
Date read
September 2026

Missouri started paying for these drugs rather than stopping, which makes it unusual among the states on this site. Its own policy document says so in as many words, describing a program that historically excluded anti-obesity medications and has begun covering select ones.

The word select is doing the same work here as in several other states, and it is doing it in an unusually sharp way. Missouri's policy names the drugs it will pay for, and then says that anti-obesity medications not listed in the policy stay excluded. That is a closed list rather than an open one, and it is why a drug you might expect to find here is simply absent.

The sharpest edge is Wegovy. Missouri covers it, but its prior authorization form states that Wegovy is not covered for reducing or maintaining body weight — the paths that remain are the other approved uses. A reader who sees Wegovy on the drug list and stops there will draw the wrong conclusion.

Missouri also removes a complication most states leave in place. Its pharmacy manual states that managed care plans do not provide pharmacy services and cannot prior authorize them, and that the state's own pharmacy program processes them for managed care members. One list, one set of rules, and no plan appeal standing between a pharmacy denial and the state.

What we could verify for Missouri

Missouri describes itself as having started coverage rather than restricted it. Its policy document states: "Historically, anti-obesity medications were excluded from MO HealthNet coverage; however, as obesity is increasingly being recognized as a complex disease requiring treatment... MO HealthNet is beginning coverage for select anti-obesity agents." The document carries a first implementation date of January 9, 2025 and a revised date of April 23, 2026 on its face.

MO HealthNet Division, Missouri Department of Social Services, effective April 2026 · source

The list of covered anti-obesity drugs is closed, and the policy says so: "Medications indicated only for anti-obesity but not listed within this policy remain excluded from MO HealthNet coverage." The policy lists Foundayo, Zepbound and Zepbound KwikPen as preferred agents and Wegovy as non-preferred.

MO HealthNet Division, Missouri Department of Social Services, effective April 2026 · source

Wegovy is on the list and is not available for weight loss as such. The state's prior authorization form states: "Wegovy for the reduction of excess body weight or maintenance of weight reduction long term is not covered by MO HealthNet." The same form adds a titration rule specific to it: "Initial approval for Wegovy is for four (4) weeks only. Subsequent approvals will be required for each dose during the titration process." The form carries no revision date anywhere on its face, so how current it is cannot be read off the document; we date it only by the day we opened it.

MO HealthNet Division, Missouri Department of Social Services (form 2575-053) · source

The entry criteria are age-banded with a BMI floor. The policy covers participants aged 12 years or older. For participants under 18 it asks for a documented baseline BMI at or above the 95th percentile standardized for age and sex; for those 18 and over, a documented baseline BMI of 30 or more, or 27 or more with at least one listed weight-related comorbid condition. Foundayo is the exception to the age band, at 18 and over.

MO HealthNet Division, Missouri Department of Social Services, effective April 2026 · source

The state regulation's weight-loss exclusion carries the coverage inside it. The pharmacy manual's table of drug classes excluded from the program lists "Drugs used to promote weight loss" and, in the column headed exceptions reimbursable, gives: "Glucagon-Like Peptide-1 (GLP-1) that are approved by the FDA for the treatment of obesity and listed as preferred on the Preferred Drug List (PDL)." The exclusion and the coverage are the same row of the same table.

MO HealthNet Division, Missouri Department of Social Services (Pharmacy Provider Manual) · source

There is no managed care drug list in Missouri to check against the state's. The pharmacy manual states: "MHD Managed Care health plans do not provide pharmacy services for their participants. The MHD Pharmacy Program processes pharmacy services for all Managed Care participants... Managed Care health plans cannot prior authorize pharmacy services." A pharmacy denial is therefore a state action rather than a plan action.

MO HealthNet Division, Missouri Department of Social Services (Pharmacy Provider Manual) · source

Missouri publishes two different appeal clocks and which one applies turns on what the state did. Where it is refusing a request, the statute gives "ninety days from the date of the notice of the action in which to request an appeal to the director of the division." Where it is cutting something already in place, the window is much shorter and carries a benefit with it: the recipient "shall have ten days from the date of the mailing of notice of the proposed action... within which to request an appeal," and "If an appeal is requested, benefits or services shall continue undiminished or unchanged until such appeal is heard and a decision has been rendered thereon." The statute adds that an appeal filed in the ninety-day period after a closing or modification does not carry continued benefits.

Section 208.080, Revised Statutes of Missouri, Missouri Revisor of Statutes, effective August 2014 · source

The state's hearing rule supplies procedure and points at the statute for the deadline: "A participant may appeal any division decision that delays, denies, or adversely affects the participant's benefits or services to the division director, pursuant to section 208.080, RSMo." It also provides an expedited route where "the participant's life, health, or ability to attain, maintain, or regain maximum function would be jeopardized by the time ordinarily permitted for a standard hearing," and allows a request to be made in person, by telephone, by mail or by electronic means the division uses.

13 CSR 40-2.160, Missouri Code of State Regulations, Missouri Secretary of State · source

Medicaid is only one of the routes. If you have a commercial or employer plan, the rules are different and are on the employer plans page; Medicare has a federal rule of its own, on the Part D page.

If the appeal fails, or you cannot wait

Cash-pay telehealth is the fallback, not the bargain: you pay the whole cost yourself, and a covered prescription is almost always cheaper than any of these. Use this route when coverage has actually been exhausted, or when you need to start while an appeal runs.

  • CoreAge RxAdvertises $99 a month for compounded semaglutide, flat across doses. Read the terms before you sign up: the lander our link opens has shown $149 rather than $99, and a consultation fee can be charged on top and may not be refundable.
  • OakFlat price across doses, free shipping with supplies.
  • Care Bare RxNames its pharmacies with addresses; sells brand Ozempic as well as compounded.
  • Gala HealthAll doses one price, but the advertised rate needs a yearly subscription.
  • Synergy RxProviders licensed in your state; publishes no GLP-1 price before the consult.
  • Breeze MedsServes all 50 states; publishes a starting price only.

Prices in those notes were read from each company's own site in August 2026 and change often. Check the current number before you buy.

Where this comes from

  1. MO HealthNet Division, Missouri Department of Social Services, effective April 2026 dss.mo.gov/media/file/glucagon-peptide-1-glp-1-receptor-agonists-indicat
  2. MO HealthNet Division, Missouri Department of Social Services (form 2575-053) dss.mo.gov/media/35771
  3. MO HealthNet Division, Missouri Department of Social Services (Pharmacy Provider Manual) dss.mo.gov/media/54921
  4. Section 208.080, Revised Statutes of Missouri, Missouri Revisor of Statutes, effective August 2014 revisor.mo.gov/main/OneSection.aspx?section=208.080
  5. 13 CSR 40-2.160, Missouri Code of State Regulations, Missouri Secretary of State www.sos.mo.gov/cmsimages/adrules/csr/current/13csr/13c40-2.pdf

Every state we have verified is in the coverage matrix. Appeal routes and deadlines are on the procedures page.